MRI Detected EMVI Post-Neoadjuvant Therapy for Rectal Cancer: Retrospective Chart Review, Recurrence, and Clinical Implications

Date

2023-05

ORCID

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

There is limited and conflicting data on the value of EMVI status on post-neoadjuvant therapy MRI reports as a prognostic indicator. The study conducted was an IRB approved retrospective chart review to assess the relationship of EMVI status on post-neoadjuvant therapy MRI reports with recurrence and survival. Data collection was conducted on Baylor University Medical Center patients that were enrolled in a multi-disciplinary tumor board for rectal cancer from 2013 to 2021. Descriptive and statistical analysis was performed that showed statistically significant differences between EMVI status on post-neoadjuvant therapy MRI reports and age, recurrence, metastasis, survival probability, and tumor regression grade.

Description

Citation

Rights

License